All peptides
MetabolicEmerging

MOTS-c

Mitochondrial open reading frame of the 12S rRNA-c · MT-RNR1-encoded peptide

A mitochondrial-encoded peptide that acts as a metabolic regulator, studied for insulin sensitivity, fat oxidation and exercise-mimetic effects.

How it works

Encoded by mitochondrial 12S rRNA, MOTS-c translocates to the nucleus and activates the folate/AMPK axis. This improves cellular glucose uptake, increases fatty-acid oxidation and promotes metabolic flexibility under nutrient stress.

Structure: 16 amino acid mitochondrial-derived peptide

Reported benefits

  • Improved insulin sensitivity and glucose disposal in rodent models
  • Enhanced fat oxidation and reduced fat accumulation
  • Exercise-mimetic effects on metabolism and physical capacity
  • Potential protection against diet-induced metabolic dysfunction

Practical considerations

  • Most evidence is preclinical; human trials are small and early-phase
  • Short half-life may require daily or twice-daily dosing
  • Bioavailability of oral forms is uncertain compared with injection

Side effects and risks

  • Limited human safety data
  • Injection-site irritation
  • Possible hypoglycaemia in susceptible individuals

MOTS-c dosing overview

Commonly cited at 5–10 mg daily, often for 4–12 week cycles

Reported MOTS-c dosing ranges by context
ContextAmountFrequencyRoute
Commonly cited protocol5–10 mgDaily or 3× weeklySubcutaneous
Cycle length—4–12 weeks—

This describes doses reported in published literature and community protocols. It is not a recommendation, and it is not a substitute for clinical supervision.

MOTS-c FAQ

What is MOTS-c?

A 16-amino-acid peptide encoded by mitochondrial DNA. It acts on metabolic signalling — notably AMPK activation — and is studied as an exercise-mimetic and insulin-sensitising factor.

Is there human evidence?

Human data is observational: MOTS-c levels rise with exercise and differ between metabolic phenotypes. Interventional dosing evidence is animal-only.

Is MOTS-c banned in sport?

Yes. WADA added mitochondrial-derived peptides including MOTS-c to the prohibited list as metabolic modulators.

Does the oral form work?

Unclear. Oral capsules are marketed, but no published pharmacokinetic study shows meaningful absorption of intact MOTS-c.

Research references

  • Lee et al., 2015 — MOTS-c as a mitochondrial-encoded regulator of metabolism
  • Reynolds et al., 2021 — MOTS-c and physical performance